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Season variation in preeclampsia – timing of delivery vs 
timing of conception 
 
Background 
Preeclampsia is a multi-system disease characterized by hypertension and proteinuria 
in pregnant women at greater than 20 weeks of gestational age.  It remains one of the 
leading causes of maternal and foetal mortality and morbidity.  
 
While the cause of preeclampsia is essentially unknown, the important theories 
strongly implicate disturbed placental function in early pregnancy.  Additionally, 
some researchers have investigated the possibility of a seasonal relationship with the 
incidence of preeclampsia.  Differences in incidences of preeclampsia, examined 
exclusively on the basis of delivery timing, have also been noted to have seasonal 
variation, but results have been inconsistent. 
 
Objective 
Our primary objective was to investigate the seasonal variation in preeclampsia in 
relation to the timing of conception and the timing of presentation with clinical 









We performed a retrospective descriptive study of all women with preeclampsia who 
delivered at Tygerberg Hospital in 2010.  Preeclampsia was diagnosed as 
hypertension associated with proteinuria after the 20th week of gestation. 
Names of patients were identified from labour ward records and data was collected 
and recorded on a data-sheet.  
 
Data were primarily analysed in relation to the season of delivery and also the season 
of the last menstruation.  Summer was diagnosed as lasting from summer solstice to 
autumn equinox, autumn as lasting from autumn equinox until winter solstice, winter 
as lasting from winter solstice until spring equinox and spring as lasting from spring 
equinox until summer solstice. 
 
The data was analysed using the SPSS software (Statistical Package for Social 
Science). Discrete data was compared by calculating relative risks with 95% 
confidence limits, as well as the chi
2
 test.  Fisher‘s exact test was used to compare 
ratios where the expected value in any cell of a two-by-two table is less than five.  
The means of normally distributed continuous data was compared by analysis of 
variance, while the medians of continuous data which are not distributed normally, 
where calculated using the non-parametric Mann Whitney u test.  A p-value of < 0.05 
was considered to be statistically significant, where applicable. 
 
 




The peak incidence of preeclampsia was during winter with 32.2% of all cases 
occurring during this season.  This was significantly higher than during the summer 
when only 169 (17.17%) cases of preeclampsia were delivered. 
 
When we analysed the data looking at the timing of menstruation (and therefore 
conception), we found that 292 (29.7%) patients that developed preeclampsia had 
their last menstrual period in the spring, with November the month of peak incidence.  
The lowest incidence was found in winter, with only 218 (22.2%) patients.  
 
Conclusion 
We have confirmed a previous finding of a seasonal variation in the occurence of 
preeclampsia in Tygerberg Hospital.  We have also confirmed that this seasonal 
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Preeclampsia is a multi-system disease characterized by de novo hypertension and 
significant proteinuria in pregnant women at greater than 20 weeks of gestational 
age.
1 
Clinically, this disease can be classified as ‗severe‘ when severe hypertension, severe 
proteinuria, or other signs or symptoms of end-organ injury are present.
2,3
  In the 
absence of any of these findings, preeclampsia can be classified as ‗mild‘.  In this 
commonly used system, there is no ‗moderate‘ classification. 
 
Globally, preeclampsia occurs in up to 7.5 percent of pregnancies.
4,5 
 It remains one of 
the leading causes of maternal, fetal and neonatal morbidity and mortality – 
accounting for 10 – 15 percent of direct maternal deaths worldwide.
6
  
   
Maternal morbidity includes the development of eclamptic convulsions, HELLP-
syndrome (haemolysis, elevated liver enzymes, low platelets), pulmonary oedema, 
abruptio placentae and temporary loss of vision – either through PRES-syndrome 
(posterior reversible encephalopathy) or serous retinal detachment.  In more severe 
cases, the patient can develop acute renal and liver failure.  If these complications are 
not appropriately managed, the patient‘s condition will deteriorate into multisystem 
organ failure and even death. Acute severe systolic hypertension (systolic pressure 
greater than 160mmHg) is also associated with an increased risk of intra-cerebral 
haemorrhage. 
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The fetal complications include intra-uterine growth restriction, placental 
insufficiency and even intra-uterine death.  Because of the intra-uterine growth 
restriction and placental insufficiency, there is also an increase in the rate of deliveries 
by caesarean section – again increasing maternal and neonatal morbidity. 
 
The neonatal complications include hyaline membrane disease, NEC (necrotizing 
enterocolitis) and intra-ventricular haemorrhage.  The neonatal complications are all 
due to prematurity – usually secondary to a worsening maternal condition 
necessitating delivery well before 34 weeks.  Though the use of antenatal steroids and 
expectant management has greatly improved the outcome for neonates, especially in 
larger centres, morbidity and mortality remain high and a great financial burden on 
any health system.  
 
While the cause of preeclampsia is essentially unknown, the pathophysiology likely 
involves both maternal and fetal or placental factors. Abnormalities in the 
development of placental vasculature early in pregnancy may result in relative 
placental hypoperfusion and hypoxia –even ischaemia - which then leads to release of 
antiangiogenic factors into the maternal circulation that alter maternal systemic 
endothelial function and cause hypertension and other manifestations of the disease. 
However, the molecular basis for placental dysregulation of these pathogenic factors 
remains unknown, and the role of angiogenic proteins in early placental vascular 
development are under investigation. 
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The critical role of the placenta in the pathophysiology of preeclampsia is supported 
by epidemiologic and experimental data that show two things.  Firstly, placental tissue 
is necessary for development of the disease, but the fetus is not.  Secondly, 
preeclampsia is always cured after delivery of the placenta.   
 
Examination of human placentas at various stages of gestation in women with normal 
pregnancies, as well as those with preeclampsia, has led to an understanding of 
normal placental morphology and pathologic changes in the uteroplacental circulation 
that are likely to be relevant to preeclampsia. 
 
Abnormal remodeling of spiral arteries — In normal pregnancies, the 
cytotrophoblast cells of the developing placenta migrate through the decidua and part 
of the myometrium to invade both the endothelium and highly muscular tunica media 
of the maternal spiral arteries, the terminal branches of the uterine artery that supply 
blood to the developing fetus/placenta. As a result, these vessels undergo 
transformation from small muscular arterioles to large capacitance vessels of low 
resistance, thus greatly facilitating blood flow to the placenta compared with other 
areas of the uterus.
7,8
  Remodeling of the spiral arteries probably begins in the late 
first trimester and is completed by 18 to 20 weeks of gestation, although the exact 
gestational age at which trophoblast invasion of these arteries ceases is unclear. 
 
By comparison, in preeclampsia, cytotrophoblast cells infiltrate the decidual portion 
of the spiral arteries, but fail to penetrate the myometrial segment.
9,10 
The spiral 
arteries fail to develop into large, tortuous vascular channels created by replacement 
Stellenbosch University  http://scholar.sun.ac.za
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of the musculoelastic wall with fibrinoid material; instead, the vessels remain narrow, 
resulting in placental hypoperfusion. This defect in deep placentation has been 
associated with development of multiple adverse pregnancy outcomes, including 
second trimester fetal death, placental infarcts, abruptio placentae, preeclampsia with 
or without intrauterine growth restriction, intrauterine growth restriction without 
maternal hypertension, premature rupture of membranes, and preterm labor.
11 
 
It is not known why the normal sequence of events in development of the 
uteroplacental circulation does not occur in some pregnancies. Vascular, 




Defective trophoblast differentiation — Defective differentiation of trophoblast is 
one possible mechanism responsible for defective trophoblast invasion of the spiral 
arteries.
13
 Trophoblast differentiation during endothelial invasion involves alteration 
in expression of a number of different classes of molecules, including cytokines, 
adhesion molecules, extracellular matrix molecules, metalloproteinases, and the class 
Ib major histocompatibility complex molecule, HLA-G.
14,15
 During normal 
differentiation, invading trophoblasts alter their adhesion molecule expression from 
those that are characteristic of epithelial cells (integrin alpha6/beta1, alphav/beta5, 
and E-cadherin) to those of endothelial cells (integrin alpha1/beta1, alphav/beta3, and 
VE-cadherin), a process referred to as pseudo-vasculogenesis
7
. Trophoblasts obtained 
from women with preeclampsia do not show upregulated adhesion molecule 
expression or pseudo-vasculogenesis. The resulting impaired placentation and 
accompanying ischemia are thought to be the primary events leading to placental 
Stellenbosch University  http://scholar.sun.ac.za
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release of soluble factors that cause systemic endothelial dysfunction resulting in the 
preeclamptic phenotype. 
 
HYPOPERFUSION, HYPOXIA, ISCHEMIA — Hypoperfusion appears to be 
both a cause and a consequence of abnormal placental development.  Hypoperfusion 
becomes more pronounced as pregnancy progresses since the abnormal uterine 
vasculature is unable to accommodate the normal rise in blood flow to the 
fetus/placenta with increasing gestational age
16-18
. Late placental changes consistent 
with ischemia include atherosis (lipid-laden cells in the wall of the arteriole), fibrinoid 
necrosis, thrombosis, sclerotic narrowing of arterioles, and placental 
infarction.
7,16,17,19,20,21
 Although all of these lesions are not uniformly found in patients 
with preeclampsia, there appears to be a correlation between the severity of the 
disease and the extent of the lesions.
22,23 
Hypoperfusion, hypoxia, and ischemia is a critical component in the pathogenesis of 
preeclampsia because the hypoperfused, ischaemic placenta elaborates a variety of 
factors into the maternal bloodstream that alter maternal endothelial cell function and 




IMMUNOLOGIC FACTORS — The focus on immunologic factors as a possible 
contributor to abnormal placental development was based, in part, upon the 
observation that prior exposure to paternal/fetal antigens appears to protect against 
preeclampsia
31-37
. Nulliparous women and women who change partners between 
pregnancies, have long interpregnancy intervals, use barrier contraception, and 
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conceive via intracytoplasmic sperm injection have less exposure to paternal antigens 
and higher risks of developing preeclampsia. 
 
Immunologic abnormalities, similar to those observed in organ rejection graft versus 
host disease, have been observed in preeclamptic women.
38
 The extravillous 
trophoblast (EVT) cells express an unusual combination of HLA class I antigens: 
HLA-C, HLA-E, and HLA-G. Natural killer (NK) cells that express a variety of 
receptors (CD94, KIR, and ILT) known to recognize class I molecules infiltrate the 
maternal decidua in close contact with the EVT cells.
39
 Interaction between NK cells 
and EVT cells has been hypothesized to control placental implantation. In 
preeclampsia, conflict between maternal and paternal genes is believed to induce 
abnormal placental implantation through increased NK cell activity. 
Placental bed biopsies from women with preeclampsia have revealed increased 
dendritic cell infiltration in preeclamptic decidual tissue.
40
 The dendritic cells are an 
important initiator of antigen-specific T-cell responses to transplantation antigens. It 
is possible that increased number of dendritic cells may result in alteration in 
presentation of maternal and fetal antigens at the decidual level, leading to either 
abnormal implantation or altered maternal immunologic response to fetal antigens. 
 
However, definitive evidence for this theory is lacking.  A systematic review found no 
clear evidence that one or several specific HLA alleles were involved in the 
pathogenesis of preeclampsia.
42
 Therefor, it has been suggested that interaction 
between maternal, paternal, and fetal HLA types, rather than any individual genotype 
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alone, was probably an important factor to consider when studying immunogenetic 
determinants of preeclampsia. 
 
A more promising finding is that patients with preeclampsia have increased levels of 
agonistic antibodies to the angiotensin AT-1 receptor. This antibody can mobilize 
intracellular free calcium and may account for increased plasminogen activator 1 
production and shallow trophoblast invasion seen in preeclampsia.
42-46
 In addition, 
angiotensin AT-1 receptor antibody stimulates sFlt-1 secretion
47
. It is unclear if these 
alterations are pathogenic or epiphenomena. 
 
INCREASED SENSITIVITY TO ANGIOTENSIN II — Increased sensitivity to 
angiotensin II has been described in preeclampsia,
48
 and may be related to increased 
bradykinin (B2) receptor upregulation in preeclamptic patients. Upregulation leads to 
heterodimerization of B2 receptors with angiotensin II type I receptors (AT1), and 
this AT1/B2 heterodimer increases responsiveness to angiotensin II in vitro.
49 
As discussed above, patients with preeclampsia have increased levels of agonistic 
antibodies to the angiotensin AT-1 receptor. Angiotensin II is the endogenous ligand 
for the AT-1 receptor, thus increased activation of this receptor by auto-antibodies 
could induce the hypertension and vascular injury observed in preeclampsia. Studies 
in mice support this theory.
50 
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GENETIC FACTORS — Although most cases of preeclampsia are sporadic, genetic 
factors are thought to play a role in disease susceptibility.
51-60
 A genetic predisposition 
to preeclampsia is suggested by the following observations: 
 Primigravid women with a family history of preeclampsia (eg, affected mother 
or sister) have a two- to five-fold higher risk of the disease than primigravid 
women with no such history.
52,53,60,61
  
 The risk of preeclampsia is increased more than seven-fold in women who 
have had preeclampsia in a previous pregnancy.
62
 
 The spouses of men who were the product of a pregnancy complicated by 




 A woman who becomes pregnant by a man whose previous partner had 
preeclampsia is at higher risk of developing the disorder than if the pregnancy 
with the previous partner was normotensive.
54
 
These data suggest that both maternal and paternal contributions to fetal genes may 
have a role in defective placentation and subsequent preeclampsia. Several candidate 
genes, such as the angiotensinogen gene variant (T235), endothelial nitric oxide 
synthase (eNOS), and genes causing thrombophilia, have been linked with 




Genome wide scanning of 343 Icelandic women with preeclampsia, eclampsia, and 
gestational hypertension revealed a significant locus at 2p13.
55
 Other susceptibility 
loci have been identified at 2p12, 2p25, and 9p13.
52,62,63
 The genes for sFlt-1(Soluble 
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fms–like tyrosine kinase 1) and Flt-1 are carried on chromosome 13. Fetuses with an 
extra copy of this chromosome (eg, trisomy 13) should produce more of these gene 
products than their normal counterparts. In fact, the incidence of preeclampsia in 
mothers who carry fetuses with trisomy 13 is greatly increased compared to all other 
trisomies or to control pregnant patients.
64
 In addition, the ratio of circulating sFlt-1 to 
PlGF(placental growth factor) is significantly increased in these women, thus 
accounting for their increased risk of preeclampsia.
65 
 
A different locus at 12q may be linked to HELLP syndrome, but not preeclampsia 
without HELLP syndrome, suggesting that genetic factors important in HELLP 
syndrome tests, may be distinct from those in preeclampsia.
57 
 






 Mother or sister with a history of preeclampsia 
Obstetric factors 
 Primiparity 
 Multiple pregnancy 
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 Previous preeclampsia 
 Long birth interval 
 Hydrops with a large placenta 
 Hydatidiform mole 
 Triploidy 
 Trisomy 13 
Medical factors 
 Pre-existing hypertension 
 Chronic kidney disease 
 Diabetes (pre-existing and gestational) 
 Antiphospholipid antibodies 
 Connective tissue disease 
 
 
The magnitude of risk depends upon the specific factor and is described below for 
selected risk factors evaluated in a systematic review of controlled studies.
66 
 A past history of preeclampsia increases the risk of developing preeclampsia 
in a subsequent pregnancy seven-fold compared to women without this history 




The severity of preeclampsia strongly impacts this risk. Women with severe 
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second trimester preeclampsia are at greatest risk of developing preeclampsia 
in a subsequent pregnancy: rates of 25 to 65 percent have been reported.
67-70 
 
By comparison, women with mild preeclampsia in their first pregnancy 
develop preeclampsia in 5 to 7 percent of second pregnancies.
71,72
 Women 
who had a normotensive first delivery develop preeclampsia in less than 1 
percent of second pregnancies. 
 First pregnancy (nulliparity) (RR 2.91, 95% CI 1.28-6.61).
66
 It is unclear why 
the primigravid state is a significant predisposing factor. One theory is that 
these women may have had limited recent exposure to paternal antigens, 
which may play a role in the pathogenesis of the disease. 
 A family history of preeclampsia in a first degree relative (RR 2.90, 95% CI 
1.70-4.93)
66
, suggesting a heritable mechanism in some cases.
73,74
 The father 
of the baby may contribute to the increased risk, as the paternal contribution to 
fetal genes may have a role in defective placentation and subsequent 
preeclampsia.  
 Preexisting medical conditions: 
 Pregestational diabetes (RR 3.56, 95% CI 2.54-4.99), an effect that is probably 
related to a variety of factors, such as underlying renal or vascular disease, 
high plasma insulin levels/insulin resistance, and abnormal lipid metabolism.
75
  
 Blood pressure ≥130/80 mm Hg at the first prenatal visit (RR 1.38-2.37)
66
. 
The risk of superimposed preeclampsia is highest in women with diastolic 
blood pressure ≥110 mm Hg (RR 5.2) and ≥100 mm Hg (RR 3.2) before 20 
weeks of gestation. 
 Antiphospholipid antibodies (RR 9.72, 95% CI 4.34-21.75).
66
  
 Body mass index  ≥ 26.1 kg/m
2
 (RR 2.47, 95% CI 1.66-3.67).
66
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 Twin pregnancies (RR 2.93, 95% 2.04-4.21).
66
 The risk increases with 
increasing number of fetuses in multiple gestations: triplet pregnancy triples 
the risk of preeclampsia compared with twin pregnancy. 
 Advanced maternal age (maternal age ≥40 RR 1.96, 95% CI 1.34-2.87 for 
multiparas and RR 1.68, 95% CI 1.23-2.29 for primiparas). Older women tend 
to have additional risk factors, such as diabetes mellitus and chronic 
hypertension. Whether adolescents are at higher risk of preeclampsia is more 
controversial
76
; a systematic review did not find an association.
66
  
Of note, women who smoke cigarettes have a lower risk of preeclampsia than 
nonsmokers. 
 
Additionally, some researchers have investigated the possibility of a seasonal 
relationship with the incidence of preeclampsia.
77-81
 A difference in incidences of 
preeclampsia, examined exclusively on the basis of timing of delivery, have also been 
noted to have seasonal variation, but results have been inconsistent. This is not 
surprising, given that the studies were conducted in dissimilar populations, regions of 
the world, and climates, where environmental exposures may fluctuate greatly.  
Moreover, even if environmental factors are fairly constant across studies, the same 
exposure may have a vastly different impact on the pathophysiologic condition of 
preeclampsia in distinct populations of pregnant women, depending on their 
underlying characteristics. 
 
In Kuwait, it was found that the incidence of pregnancy-induced hypertension per 
1,000 deliveries was high in June when the temperature was very high and the 
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humidity at its lowest. Interestingly, the reverse was true for preeclampsia.  The 
incidence of preeclampsia was highest in November when the temperature was low 
and the humidity high.
78
   
 
In Norway, a country with substantial differences in climate in summer and winter, 
Magnus et al aimed to demonstrate a seasonal pattern in the incidence of 
preeclampsia.  Among all 1,869,388 births from 1967–1998 in 
Norway, 51,801 (2.77%) were recorded with preeclampsia. The incidence of 
preeclampsia was found to be highest (3.08%) in December. The incidence declined 
during spring and summer to the lowest level (2.46%) in August and then increased 
again gradually in the autumn months.  The prevalence ratio for preeclampsia was 
1.25 for December, with August as the reference month.  Adjustment for other 
variables did not alter the seasonal trend in occurrence of preeclampsia.  
 
 In Zimbabwe, a study by Wacker et al supported the concept of a seasonal change for 
preeclampsia.  At the start of the rainy season there was a peak incidence of 
preeclampsia.  On the other hand a lower incidence of preeclampsia can be found in 
months with a very low or even no rainfall.  It is questionable whether this 
phenomenon is explained by a direct connection between humidity and temperature 
on blood pressure or by an indirect effect of the climate via other factors.  
 
In a recent publication it was reported that preeclampsia occurred more often at 
Tygerberg Hospital
82
 during the winter months.  (13.6% of admissions in winter vs. 
11.5% of all annual admissions).  Women admitted in winter had a higher risk of 
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developing preeclampsia compared to those admitted in summer (OR_1.69, 95% CI: 
1.07_1.53). The risk of developing preeclampsia in June was significantly higher than 
in February (OR_2.81, 95% CI: 2.06_ 3.83). However, one shortcoming of that study 
was the unavailability of gestational age at the time of delivery.  This may be 
important, as underlying factors which may play a role in the development of 
preeclampsia may do so nearer to the time of conception rather than at the time of 
clinical recognition of disease.
83 
 
It is unclear why a seasonal variation in preeclampsia is found.  Other studies have 
also shown seasonal variation in diseases, such as cardiovascular events.
89,90
  Winter 
peaks have been reported for myocardial infarction, fatal pulmonary thrombo-
embolism, deep venous thrombosis and non-traumatic rupture of the thoracic aorta. 
This evidence suggests that diseases might be influenced by weather conditions. 
 
Some hypotheses have been presented to explain the variation specifically in 
preeclampsia.  There is growing evidence of increased enhanced maternal 
intravascular systemic inflammatory response in patients with preeclampsia.
1
  
Maternal infections may enhance this response.  Seasonal fluctuations in infections 
may lead to variability in the seasonal occurrence of preeclampsia.
84
 Seasonal 
variation in preeclampsia has also been linked to diet.
80 
  
In humans, plasma volume demonstrates seasonal variation.  Plasma volume contracts 
during the winter months and expands in the warm summer months.
85
 There is 
evidence that pre-conceptual factors influencing plasma volume may be central to the 
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development of preeclampsia.  This may contribute to the seasonal variation 
previously referred to.  It is plausible that the incidence of preeclampsia would be 
highest if conception occurred shortly after the prolonged plasma volume constriction 
of winter. This would account for a potentially accelerated volume expansion in early 
pregnancy (during the summer) superimposed on a volume-restricted condition.
86 
 
In our study, we aim to analyze the incidence of preeclampsia by both the timing of 
delivery AND the timing of conception.  As Tygerberg hospital is a referral center 
and a tertiary level hospital, this study could provide valuable information in 
predicting and managing an increased patient load.  It will also allow us to improve 
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Materials and methods 
 
We performed a retrospective descriptive study of all women with preeclampsia who 
delivered at Tygerberg Hospital in 2010.  Names of patients were identified from 
labour ward records.  In addition, the records of all women from the department 
where a platelet count as well as a haemoglobin value were done in 2010 were traced 
and examined to determine whether she had preeclampsia.   
 
Preeclampsia was diagnosed as hypertension associated with proteinuria after the 20th 
week of gestation.
84
 Hypertension was defined as a blood pressure of at least140 / 90 
mm Hg on at least two occasions 4–6 h apart.  Proteinuria was defined as the 
excretion of 300 mg or more of protein in a 24 h period or as a protein>1 + on 
dipstick in at least two random urine samples taken at least 4–6 h apart. 
 
Once the folder was located, data was collected and recorded on a data-sheet.  Apart 
from demographic data, previous pregnancy outcomes as well as previous medical 
and surgical history were documented.   
 
Duration of pregnancy was considered to be accurate if the date of last menstruation 
was known and corresponded to the clinical examination or an ultrasound performed 
before 24 weeks′ gestation, or alternatively if an early ultrasound was available 
without the patient being certain of her last menstruation.  Duration of pregnancy 
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based on SF-measurement or a late ultrasound was considered to be uncertain.  
Laboratory investigations were documented and considered to be abnormal based on 
local laboratory recommendations.  All antihypertensive drugs used, as well as the use 
of MgSO4 and heparin, were recorded.  Initial management was divided into 
stabilisation and delivery, where the intention was to deliver the patient not longer 
than 48 hours after admission, or expectant, where the managing physician planned to 
postpone delivery for more than 48 hours.  Vaginal delivery was divided into 
following spontaneous onset or induction of labour.  Methods of induction of labour 
could include misoprostol, prepidil®, oxytocin or artificial rupture of membranes.  
Indications for caesarean section were divided into the following groups: fetal distress 
(including abruptio placentae), failed induction of labour, maternal condition or other.  
The last umbilical artery Doppler test was recorded and was reported as below the 
75
th
 centile (p75), between p75 and p95, above p95, absent enddiastolic velocity and 
reversed end diastolic velocity.
87
  
Complications were defined as follows: 
 Eclampsia:  Eclampsia is defined as the onset of convulsions in a woman with 
preeclampsia. 
 HELLP syndrome: The diagnosis is established by the following criteria: 
 Microangiopathic hemolytic anemia with characteristic schistocytes on blood 
smear 
 Platelet count <100,000 cells/µL 
 Serum lactate dehydrogenase >600 IU/L or total bilirubin >1.2 mg/dL 
 Serum aspartate aminotransferase (AST) >70 IU/L 
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 Pulmonary edema: Clinically diagnosed, confirmed by chest X-ray  
 Intracranial haemorrhage:  Diagnosed by computerised tomography  
 Liver failure:  Clinically diagnosed in a patient with jaundice and encephalopathy, 
confirmed by raised transaminases 
 Renal injury or insult:  Serum creatinine doubles 
 Renal failure: Serum creatinine increases 3-fold 
 Ascites: Clinically diagnosed ascites confirmed by ultrasound 
 Placental insufficiency / Intrauterine growth restriction (IUGR):  Estimated fetal 
weight below the 10 centile for gestational age with abnormal umbilical artery 
dopplers 
 Abruptio placentae:  the typical clinical picture (bleeding after 20 weeks 
gestational age, an irritable or hypertonic uterus and a tender uterus or abdominal 
pain) or a retroplacental clot causing an indentation covering 15% or more of the 
maternal surface of the placenta or histological proven abruptio placentae. 
Data were primarily analysed in relation to the season of delivery and also the 
preconception season.  Summer was diagnosed as lasting from summer solstice (21 
December) to autumn equinox (20 March), autumn as lasting from autumn equinoxtill 
winter solstice (21 June), winter as lasting from winter solstice till spring equinox (23 
September) and spring as lasting from spring equinox till summer solstice.
88
  
The date of the last normal menstruation was accepted in the cases where patients 
were certain of their dates if the dates corellated with clinical findings.  When any 
other way was used to calculate the gestational age, the date of the last normal 
menstruation was extrapolated as day 0 in relation to the calculated gestational age in 
days.  The same analyses in relation to the season of delivery and the season of the 
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last menstruation were repeated for both all patients and only patients where the date 
of the last normal menstruation was certain. 
The data was analyzed using the SPSS software (Statistical Package for Social 
Science). Discrete data was compared by calculating relative risks with 95% 
confidence limits, as well as the chi
2
 test.  Fisher‘s exact test was used to compare 
ratios where the expected value in any cell of a two-by-two table is less than five.  
The means of normally distributed continuous data was compared by analysis of 
variance, while the medians of continuous data which are not distributed normally, 
where calculated using the non-parametric Mann Whitney u test.  A p-value of < 0.05 
was considered to be statistically significant, where applicable.   
The study protocol was approved by the Committee for Human Research, of the 
University of Stellenbosch (Project Number: N11/06/190). 
 
  





Analyses based on season of delivery 
 
We admitted 984 patients with preeclampsia during 2010.  Of these women, 169 
delivered in summer, 264 in the autumn, 317 in winter and 234 in spring.  (Table 1).  
There were no differences in the demographics of mothers who delivered in the 
various seasons, but the gestational age at delivery was significantly higher in summer 
than in spring.   
 
 
 Summer Autumn Winter Spring All p-
value 













Gravidity 1 (1 – 8) 2 (1 – 7) 1 (1 – 9) 2 (1 – 7) 2 (1 – 9) 0.389 
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There was a significant difference in the number of women admitted with 
preeclampsia in each of the four seasons compared with the other three (Table 2, p < 
0.001), as well as between those who delivered in the different months of the year.  
(Table 3, p < 0.001 ).  There was a similar significant difference when the distribution 






Summer Autumn Winter Spring 
All 
patients  
Total Births 1489 1541 1669 1595 6294 
Preeclampsia cases 169 264 317 234 984 
% of deliveries with 
preeclampsia 11.35 17.14 18.99 14.67 
15.63 
Preeclampsia cases < 34 
weeks' gestation 
49 98 102 91 340 
% of deliveries with 
preeclampsia < 34 weeks' 
gestation 
3.29 6.36 6.11 5.71 5.40 
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Month Cases 
Total births during 
month 
Cases as % of total 
births  
% of annual 
cases  
January 89 508 17.5 9.0 
February 38 460 8.3 3.9 
March 37 503 7.4 3.8 
April 99 527 18.8 10.1 
May 92 514 17.9 9.3 
June 83 506 16.4 8.4 
July 104 584 17.8 10.6 
August 101 568 17.8 10.3 
September 113 523 21.6 11.5 
October 85 534 15.9 8.6 
November 76 559 13.6 7.7 
December 67 508 13.2 6.8 
 











Stellenbosch University  http://scholar.sun.ac.za
 33 
The gestational age at delivery remained significantly different if only mothers where 






Figure 1:  The mean and standard deviation of the gestational age at birth in days, 




























Stellenbosch University  http://scholar.sun.ac.za
 34 
Fifty-eight women presented before 28 weeks' gestation.  (Table 4, p = 0.005).   The 





 Summer Autumn Winter Spring All 
<24 Weeks(w) 0 0 1 2 3 
24w – 27w6days(d) 6 9 21 19 55 
28w – 33w6d 43 89 80 70 282 
34w – 37w6d 49 76 96 69 290 
≥38w 71 90 119 74 354 
TOTAL 169 264 317 234 984 
Table 4:  The distribution of gestational age at birth in categories depending on the 
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Figure 2:  The distribution of gestational age as percentages above and below 34 
weeks‘ gestation in the different seasons of birth. 
 
The gestational age could be determined accurately in two-thirds of all women.  
(Table 5).  The level of accurate dates did not differ between seasons.  The method 
used to calculate the gestational age could not be determined in 9 cases.  
 
 
Summer Autumn Winter Spring Total 









































Summer Autumn Winter Spring
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While expectant management was attempted in 11.5% of all cases, management did 
not differ during the different seasons of delivery.  (Table 6).    
 
 Summer Autumn Winter Spring TOTAL 
Expectant management 21 29 30 33 113 
Stabilise and deliver 148 235 287 201 871 
 169 264 317 234 984 
Table 6:  The distribution of attempts to expectant management according to season 
of birth.   
 
This was also true when analysis was limited to only cases which would have 
normally been considered for expectant management, namely those who presented 
between 24 weeks' gestation but before 34 weeks' gestation.  (Table 7).   
 
 Summer Autumn Winter Spring TOTAL 
Expectant management 15 23 25 23 86 
Stabilise and deliver 34 75 76 66 251 
 49 98 101 89 337 
 
Table 7:  The distribution of attempts to expectant management according to season 
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There was no difference in days gained with expectant management in women 
delivering in the different seasons.  (Table 8). 
 
 Median (minimum – maximum) 
Summer 8 (1 – 24) 
Autumn  10 (3 – 28) 
Winter 8 (3 – 19) 
Spring 10 (1 – 30) 
Table 8: The median number of days gained with expectant management according to 
the season of delivery.   
 
Induction of labour was attempted in 248 cases.  There was no difference in the 
number of cases in each season where induction of labour was attempted.  (Table 9, p 
= 0.11).  The methods used to induce labour differed significantly depending on the 
season birth.  (Table 10, p = 0.001). 
 Summer Autumn Winter Spring 
Cases where induction of labour was 
attempted 
45 56 93 54 
Percentage of all pre-eclamptics where 
induction of labour was attempted 26.6 21.2 29.3 23.1 
Table 9:  The number of cases where induction of labour was attempted based on the 
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Summer  Autumn Winter Spring  
Misoprostol 17 20 44 23 
ROM / Oxytocin 3 24 48 18 
Prepidil 24 12 20 13 
 
Table 10:  The methods used for induction of labour according to season of delivery.   
 
The caesarean section incidence was 59.8%.  This did not depend on the season of 
delivery.  (Table 11, p = 0.33).  The indication for caesarean section did not depend 
on the season of delivery.  (Table 11. p= 0.56). 
 
 Summer (n = 
169) 
Autumn (n = 
264) 
Winter (n = 
317) 
Spring (n = 
234) 
Caesarean sections 94 170 178 146 
 Fetal Distress 41 103 98 96 
 Failed induction of 
labour  
19 23 29 21 
 Maternal 11 9 12 5 
 Other  22 35 39 23 
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The mean creatinine values were significantly higher in autumn than in spring (Table 































2.47 ± 100.70 ± 
  1.96 27.93 1.65  171.94 557.65 3.12 37.48 








2.44 ± 111.86 ± 
  3.43 75.41 1.99  564.88 1463.71 3.33 34.86 








2.435 ± 123.21 ± 
 2.80 44.60 5.26  329.17 632.08 3.42 77.65 









3.05 ± 82.68 ± 
 2.40 40.64 2.50  242.40 436.42 3.32 20.52 








2.62 ± 100.22 ± 
 2.78 52.26 12.63  367.90 914.07 3.29 44.17 
Table 12:  The results of laboratory investigations (mean ± standard deviation) in the 
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There was a statistically significant difference in the number of women receiving 
different medications in the different seasons of birth.  (Table 13).   
 Summer Autumn Winter Spring All p-value 
Methyldopa  58.0 64.0 44.8 51.3 53.8 0.0001 
Nifedipine 68.0 90.2 97.2 97.9 90.4 0.0001 
Nifedipine XL 51.5 48.9 30.6 46.2 42.8 0.0001 
Labetalol 14.8 10.6 18.9 23.1 17.0 0.002 
MgSO4 30.2 29.2 24.6 41.5 30.8 0.0001 
Heparin 18.3 14.8 11.0 9.0 12.8 0.023 
Table 13:  The percentage of women delivering in the various seasons of the year who 
required different medications. 
 
Two hundred and fifteen women underwent a Doppler assessment of the umbilical 
artery.  Fifty-two women (5.3%) had either absent end-diastolic flow (AEDF) or 
reversed end-diastolic flow (REDF).  There were no statistically significant 
differences in the distribution of Doppler results in the different seasons.   
 
 Summer Autumn  Winter Spring All 
< 75
th





 centile 10 20 22 16 68 
> 95
th
 Centile 6 17 6 9 38 
AEDF 5 7 13 13 38 
REDF 5 1 3 5 14 
Table 14:  The distribution of normal and abnormal umbilical artery Doppler tests 
during the various seasons. 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 41 
 
The occurrence of different complications in each of the seasons of delivery is 
depicted in Table 15.    There were no statistically significant differences in any of the 
groups.   
 
Summer 
(n = 169) 
Autumn 
(n = 264) 
Winter 
(n = 317) 
Spring 
(n = 234) 
All (n 
= 984) 
Eclampsia 15 27 23 17 
82 
HELLP syndrome 13 17 21 21 
72 
Pulmonary embolus 5 7 6 6 
24 
Intracranial haemorrhage 1 0 0 0 
1 
Liver failure 0 0 0 0 
0 
Renal injury 6 22 18 8 
54 
Renal failure 1 4 4 4 
13 
Ascites 9 6 13 10 
38 
Placental insufficiency  11 26 23 22 
82 
Intrauterine death 2 7 13 11 
33 
Abruptio placentae  5 10 14 13 
42 
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Some determinants of the pregnancy outcome are shown in table 16.  The neonatal 
and placental weights were significantly higher in summer.  The same level of 
statistical significance was found when only liveborn babies were considered.  
(Placental data not shown for liveborns).  There was no difference in five minute 




























88 547.3 ± 
184.5 
9 (0 – 
10) 
10 (0 – 
10) 
10 (0 – 
10) 
Autumn 







8 (0 – 
10) 
9 (0 – 
10) 








150 526.0 ± 
194.1 
8 (0 – 
10) 
9 (0 – 
10) 








108 485.0 ± 
177.2 
8 (0 – 
10) 
9 (0 – 
10) 
10 (0 – 
10) 














More women who delivered in summer admitted to smoking.  (Table 17, p = 0.047).  
There was no difference in the reported incidence of alcohol or drug abuse. 
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Summer (n = 
169)  
Autumn (n = 
264) 
Winter (n = 
317) 
Spring  (n = 
234) 
Smokers  39 (23.1%) 38 (14.4%) 42 (13.2%) 38 (16.2%) 
Alcohol 
abusers 25 22 27 20 
Drug abusers 6 5 3 0 
Table 17:  Users of tobacco, alcohol and drugs according to season of delivery.   
 
 
Analyses based on season of assumed conception 
 
Almost 30% of women with preeclampsia had their last menstrual period during the 
spring, while the smallest number of women last menstruated in winter.  (Table18).  
The distribution of last menstrual period according to month is illustrated in table 19.   
 
SEASON n Percentage  of pre-eclamptics 
Summer 245 24.9 
Autumn 229 23.3 
Winter 218 22.2 
Spring 292 29.7 
 
Table: 18 The occurrence of preeclampsia according to the season during which the 






MONTH n Percentage  of pre-
eclamptics 
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January 89 9.0 
February 74 7.5 
March 80 8.1 
April 97 9.9 
May 58 5.9 
June 65 6.6 
July 55 5.6 
August 80 8.1 
September 94 9.6 
October 87 8.8 
November 111 11.3 
December 94 9.6 
 
Table: 19 The occurrence of preeclampsia according to the month during which the 




There were no differences in the demographics of mothers who had their last normal 
menstruation in the various seasons, but the gestational age at delivery was 
significantly higher in women who menstruated in winter than in summer.  This 
difference remained when only women with certain gestational age were considered.   
The gestational age at delivery of women with certain gestational age who last 
menstruated in winter was 254.9 ± 25.9 days compared with 240.7 ± 31.2 days in the 
group who menstruated in summer.  (p = 0.0004). 





Summer Autumn Winter Spring All 
p-
value 










Gravidity 2 (1 – 7) 2 (1 – 7) 1 (1 – 8) 2 (1 – 9) 2 (1 – 9) 0.79 
Parity 0 (0 – 5) 0 (0 – 5) 0 (0 – 5) 0 (0 – 8) 0 (0 – 8) 0.44 
Maternal 
weight 












































Table 20: Some demographic detail of women with preeclampsia depending on the 
















The laboratory test results of women were not influenced by the season of their last 
normal menstruation.  (Table 21).    
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Table 21:  The distribution of laboratory results depending on the season of last 
menstruation.
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The medication required differed significantly when analysis was performed in the 




Figure 3:  The percentage of women receiving different medications based on the 




There were 337 cases where the gestational age was more than 168 days (24 weeks) 
but less than 238 days (34 weeks).  Expectant management was attempted in 113 
cases.  Expectant management was attempted significantly more often in women who 
had last menstruated in autumn.  (Table 22, p = 0.048).   
 
Immediate Management Summer Autumn Winter Spring 
Expectant  26 38 20 29 
Stabilize and delivered 219 191 198 263 
Table 22:  the initial approach to management of women with preeclampsia according 



















Methyldopa Nifedipine Nifedipine XL Labetalol MgSO4 Heparin
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Significantly more days were gained with expectant management in women who had 
last menstruated in autumn.  (Table 23). 
 
 
 Median (minimum – maximum) 
Summer 7.5 (2 – 19) 
Autumn  12.5 (1 – 30) 
Winter 8 (1 – 28) 
Spring 8 (3 – 19) 
Table 23: The median number of days gained with expectant management according 
to the last menstruation of the woman.   
 
 
Induction of labour was attempted in 248 cases.  There was no difference in the 
number of cases in each season where induction of labour was attempted.  (Table 24, 
p = 0.19).  However, the primary methods used to induce labour differed significantly 
depending on the season of the last normal menstruation.  (Table 25, p = 0.002). 
 
 
 Summer Autumn Winter Spring 
Cases where induction of labour was 
attempted 
58 54 49 87 
Percentage of all preeclamptics where 
induction of labour was attempted 23.7 23.6 22.5 29.8 
Table 24:  The number of cases where induction of labour was attempted based on the 
last normal menstruation.   
  






Summer  Autumn Winter Spring  
Misoprostol 26 17 18 43 
ROM / Oxytocin 21 9 18 25 
Prepidil 10 27 13 19 
Unknown 1 1 0 0 
 
 
Table 25:  The methods used for induction of labour according to last normal 
menstruation.   
 
 
The caesarean section incidence was 59.8%.  This did not depend on the season of last 
menstruation.  (Table 26, p = 0.33).  The indication for caesarean section did not 




 Summer (n = 
245) 
Autumn (n = 
229) 
Winter (n = 
218) 
Spring (n = 
292) 
Caesarean sections 153 144 127 164 
 Fetal Distress 91 79 73 95 
 Failed induction of 
labour  
28 24 19 20 
 Maternal 11 9 8 9 
 Other  23 30 27 40 
 
Table 26:  The indications for caesarean section according to last normal 
menstruation.   
 





There was no difference in the degree of abnormality found in the 215 women who 





 Summer  Autumn Winter Spring  Total 
Below 75
th





 centile 23 16 14 15 68 
95
th
 centile and above 6 12 6 14 38 
Absent enddiastolic flow velocity 6 17 7 8 38 
Reversed enddiastolic flow velocity 4 4 3 3 14 
TOTAL  51 59 45 60 215 
 










The season of last normal menstruation did not influence the incidence of 
complications as depicted in table 28. 
 
 
 Summer Autumn Winter Spring  






Eclampsia 18 24 21 19 0.33 
HELLP syndrome 21 19 13 19 0.62 
Pulmonary edema 9 6 4 5 0.40 
Intracranial 
haemorrhage  
0 0 1 0 0.32 
Liver failure 0 0 0 0 * 
Renal injury/insult 16 7 13 18 0.06 
Renal failure 3 3 2 5 0.89 
Ascites  7 12 8 11 0.60 
Pl ins/IUGR 21 22 16 23 0.83 
Intrauterine death 12 5 4 12 0.18 
Abruptio placentae  14 9 10 9 0.50 
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Some determinants of the pregnancy outcome are summarized in table 29.  The 
neonatal and placental weights were significantly higher in women whose last normal 
menstruation was in spring or winter.  The same level of statistical significance was 
found when only liveborn babies were considered.  (Placental data not shown for 



































































































More women who menstruated in summer admitted to smoking.  (Table 30, p = 
0.047).  There was no difference in the reported incidence of alcohol or drug abuse. 
 







Summer (n = 
245)  
Autumn (n = 
229) 
Winter (n = 
218) 
Spring  (n = 
292) 
Smokers  42 (20.5%) 47 (15.1%) 24 (17.1%) 44 (11.0%) 
Alcohol 
abusers 27 23 22 22 
Drug abusers 0 5 5 4 
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We have confirmed a previous finding of a seasonal variation in the occurence of 
preeclampsia in Tygerberg Hospital.  This was also demonstrated in several other 
studies reported from over the globe.
80,81
  However, in the previous study from this 
unit data were extracted from daily statistics forms of the department and not from the 
folders of individual patients as we did in our study.  We were certain of the diagnosis 
of preeclampsia in each patient.   
 
The peak incidence of preeclampsia was during winter with almost one third (32.2%) 
of all cases occurring during this season.  In addition, almost one out of four of all 
deliveries in winter happened in women with preeclampsia.  As before, this was 
significantly higher than during the summer when only 169 (17.17%) cases of 
preeclampsia were delivered. This accounted for only 11.48% of all deliveries (1472) 
during the summer months. 
 
Patients with preeclampsia are a major burden on any health system.  They require 
more frequent and intensive monitoring and management.  They develop 
complications necessitating a longer stay in hospital, often in a high care or intensive 
care level bed.  They often deliver prematurely – either because of maternal 
complications or placental insufficiency – leading to increased morbidity and 
mortality for the neonate.  All of the above require beds and staff.   
 
By proving that more preeclamptics deliver in the colder winter months, we can 
prepare ourselves and ensure that sufficient infrastructure is in place to manage this 
added burden.  This can range from temporarily employing more staff – nurses and 
doctors (paediatricians and obstetricians) - to arranging additional theatre time for 
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caesarean sections and increasing our capacity to manage high care patients and 
prematurely born infants.   
 
As Tygerberg is a referral center, our data and findings can also be used to motivate 
on a provincial level for the upgrading of the referral system and patient transport 
services. 
 
An exciting possible application of our results is the counselling of patients at high 
risk of developing preeclampsia regarding the planning of future pregnancies.   
 
Although the precise aetiology of preeclampsia is still unknown, several risk factors 
for developing the disease have been identified.  Many of them – like age, previous 
preeclampsia, family members with preeclampsia and medical diseases – cannot be 
altered.  However, one of the few factors that a patient can control (to a certain extent) 
is the timing of conception.   
 
When we analyzed the data looking at the timing of menstruation (and therefore 
conception), we found that 292 (29.7%) patients that developed preeclampsia had 
their last menstrual period in the spring, with November the month of peak incidence.  
The lowest incidence was found in winter, with only 218 (22.2%) patients.  
 
This is at odds with what Phillips reported from Burlington.
83
 Whilst they analyzed 
only primigravid patients, they found a peak incidence of preeclampsia with 
conception in the summer months (June through August), with no real difference 
between autumn, winter and spring. 
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Does this mean that we should be counselling patients at high risk of developing 
preeclampsia that they should try to conceive during the winter months? And if they 
should fail to conceive during the winter?  Should they postpone trying until after the 
spring or should they wait for a year until the following winter?  What about different 
populations? Rural vs urban? Does ethinicity factor into the equation? 
 
These and other questions have arisen from our research and are still unanswered as 
data is limited.  A large, multi-centre prospective study, looking specifically at the 
timing of conception and the development of preeclampsia in different populations, 
could go a long way to establishing guidelines for the counselling of high risk 
patients.   
 
In the meantime - in the absence of better guidelines - our results should be used at 
Tygerberg Hospital in the counselling of patients at high risk of developing 
preeclampsia.  We recommend that these patients should try to conceive in the winter 
months, especially those that have had previous severe, early onset disease. 
 
This brings up the next question – if the onset of disease varies, does that mean that 
the severity of disease also has seasonal variation?  It is not unlikely, as preeclampsia 
has been characterized by some investigators into 2 different disease entities: early-
onset preeclampsia and late-onset preeclampsia.  Although the presenting features 
overlap, they are associated with different maternal and fetal outcomes, biochemical 
markers, heritability, and clinical features.
91 
Stellenbosch University  http://scholar.sun.ac.za
 57 
 
The neonatal (2436.4g ± 929.6g and placental (547.3g ± 184.5g) weights were 
significantly higher in babies born in the summer.  The weights were lowest in those 
born in the spring - 2153.8g ± 951g and 485.0g ±177.2g respectively.  The same level 
of statistical significance was found when only liveborn babies were considered.  
There was no difference in five minute Apgar scores < 7 between the seasons of 
delivery.   
 
When analysing birth weight according to the season of the last menstrual period, we 
find that the neonatal and placental weights were significantly higher in women 
whose last normal menstruation was in spring (2335.15g ± 873.2g) or winter 
(2382.63g ± 820.6g).  The lowest weights for neonates (2151.20g ± 906.8g) and 
placentas (480.4g ± 177.1g) were found in women whose last menstrual period was in 
the summer.  The same level of statistical significance was found when only liveborn 
babies were considered.  Again, no difference was found in the five minute Apgar 
scores < 7. 
 
The reasons for these differences are unclear.  It is most likely related to placental 
development and the degree of placental insufficiency.  It might also be related purely 
to the slightly more advanced gestational age at the time of delivery in the summer 
(252.4d 
± 
29.0d) vs the spring (243.5d 
± 
31.2d).  It would also be interesting to see if 
the differences in birth weight remains statistically significant in future studies if 
greater numbers of patients are analysed. 
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Further research and long term follow-up of these babies is needed to ascertain 
whether this increase in birth weight does indeed equate to a decrease in morbidity 
and mortality and a better outcome overall. 
It is important to note that we managed to determine the gestational age at delivery 
(and therefore the last normal menstrual period and timing of conception) accurately 
in only 66% of cases.  This is a common problem in obstetrics in Southern Africa, 
especially in the lower socio-economic groups. There are multiple reasons for this, 
with a lack of education and resources being amongst the most prominent. Whilst this 
does allow for a certain amount of bias in our study, the same trends were found when 
analyzing the entire group of preeclamptic patients as when only those with certain 
gestation was analyzed.  
 
Expectant management – as defined in Tygerberg Hospital – is offered selectively to 
patients who present with early onset severe preeclampsia.  They are managed 
exptectantly with the aim of improving fetal outcome by increasing the gestational 
age of the fetus at delivery.  To ensure the safety of the mom, the patient is evaluated 
twice daily for any progression of disease and biochemistry is checked twice a week.  
The fetus  is given a course of antenatal steroids (betamethasone) and qualifies for 6-
hourly CTG-monitoring, as well as weekly growth scans and full Dopplers.   Where 
patients gain more than 7 days, a second half course of steroids is usually given. 
 
This management was offered to 11.5% of all patients that presented with 
preeclampsia.  Note that our data does not allow for the analysis of why only this 
small percentage of patients qualified for expectant management.  
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There was no difference in the management during different seasons (expectant vs 
―stabilise and deliver‖) based on the timing of delivery, nor was there any difference 
in the amount of days gained in one season over another when expectant management 
was attempted. 
 
However, significantly more women were offered expectant management when their 
last menstruation was during the autumn months (19.90%).  They also successfully 
gained the most days when offered expectant management – a median of 12.5 days.  
Comparably, those who last menstruated during winter had the lowest number of 
cases managed expectantly (9.17%), with those whose last menstrual period fell in 
summer gaining the least number of days (median of 7.5) with expectant 
management.  
 
There was a statistically significant difference in the medication prescribed for the 
management of  patients with preeclampsia.  This held true when data was analysed 
based on both the timing of delivery and the timing of conception.  The reasons for 
this are unclear.  It might be due to the rotation of new interns starting in the 
department every four months or ther availability of one agent over another.  Some 
doctors favour certain drugs as a matter of personal preference.  It might also be 
linked to the severity of disease, although more evidence is needed to confirm this.   
 
When analising the data based on timing of delivery, it is evident that nifedipine was 
the drug that was used most often (90.4%).  This makes sense, as it is our first-line 
agent in the management of acute severe hypertension – systolic blood pressure 
greater than 160mm Hg or diastolic pressure greater than 110mm Hg.  It is interesting 
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to note that only 68% of patients needed this drug in the summer months, while the 
incidence was greater than 90% in all three of the other seasons – peaking at 97.9% in 
the spring.  Spring was also the season in which most of our patients required 
labetalol (23.1%) – our intravenous agent for the management of acute severe 
hypertension not responding to oral agents. 
 
More patients received methyldopa (our first-line maintenance therapy) – 53.8%, with 
peak incidence in the autumn (64%) - than nifedipine XL (our second-line 
maintenance therapy) – 42.8%., with peak incidence in the summer (51.5%).  Almost 
a third of patients (30.8%) required magnesium sulphate, with 41.5% needing it in the 
springtime. We did not analyse how many patients needed more than one agent to 
control their blood pressure or whether patients were changed from one drug to 
another, and if so, for what reason. 
 
Looking at the season of last menstruation, it appears that methyldopa is now the 
agent most often prescribed, with peak incidence in the winter.  Nifedipine and 
nifedipine XL seem to have an almost identical distribution, peaking in the autumn 
months.  Both labetalol and magnesium sulphate peaked in the summer. 
 
There was no difference in the number of successful inductions in each season based 
on either the date of delivery or the date of last menstrual period.  However, in both 
instances the method used in the different seasons showed statistical significance.  
Note that when inductions failed to establish labour, or where patients developed fetal 
distress, these cases were analysed under causes for caesarean section. 
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When analysing the data using timing of delivery, we found that both misoprostol (44 
cases) and the artificial rupture of membranes followed by the use of oxytocin (48 
cases), were most commonly used in winter.  Prepidil was most commonly used in the 
summer, with 24 cases. 
 
Looking at the timing of last menstruation, both misoprostol (43 cases) and artificial 
rupture of membranes (25 cases) now favoured those whose last menstrual period was 
in the spring.  Prepidil (27 cases) was now mostly used for those whose last period 
was in the autumn. 
 
The incidence of caesarean section did not favour a specific season, nor was there any 
significant seasonal variation in the indication for caesarean section.  This was true 
regardless of whether data was analysed using timing of delivery of timing of last 
menstrual period. 
 
Every patient admitted with preeclampsia had the following biochemical tests done – 
serum urea, creatinine, haemoglobin and platelet count.  Where the platelet count 
suggested HELLP-syndrome, AST and LDH were also requested.  Patients that 
qualified for expectant management also had their daily urine protein quantified in 
g/24hr.   
 
The mean creatinine values were significantly highest in autumn (83,91mmol/l), with 
the lowest values recorded in spring (64.46mmol/l).  None of the other biochemical 
tests differed between the seasons.  None of the laboratory results were influenced by 
the season during which the last menstruation took place. 
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Where possible, patients that present with preeclampsia to Tygerberg Hospital 
routinely get at least an umbilical artery doppler to assess the placental function 
(verwysing oor belang daarvan).  In those that qualify for expectant management, we 
also evaluate the uterine arteries to look for notching, as well as the ductus venosus.    
In our study we found no statistically significant differences in the distribution of 
Doppler results in the different seasons for either the timing of delivery or the timing 
of last menstrual period. 
 
The final aspect that we evaluated was the rate of complications experienced by 
patients with preeclampsia. These included, but were not limited to, the following: 
eclampsia, HELLP syndrome, pulmonary embolism, intra-cranial haemorrhage, liver 
failure, renal injury/failure, ascites, placental insufficiency, intra-uterine demise and 
abruptio placentae.  These complications are extremely relevant, as preeclampsia 
remains one of the leading causes of maternal, fetal and neonatal morbidity and 
mortality – accounting for 10 – 15% of direct maternal deaths worldwide.  At 
Tygerberg Hospital, 3 out of 17 maternal deaths in 2010 were due to preeclampsia.  
 
Neither the season of delivery nor the season of last menstruation had any statistically 
significant impact on the distribution of the complications of preeclampsia.   
 
These results, along with the limited seasonal variation in biochemical markers and 
the absence of significance in the seasonal variation in Doppler flow, strongly suggest 
that there was not any significant variation in the severity of disease diagnosed during 
the different seasons. 
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Our study has again proven that there is indeed a seasonal variation in the incidence 
of preeclampsia.  We have gone one step further and proven that this variation is not 
just based on the timing of delivery, but that preeclampsia also varies according to the 
season during which the last menstrual period (and therefore conception) takes place. 
 
The reasons for this are still unknown, but theories suggest it is linked to the seasonal 
change in plasma volume experienced.  Other possible causes include dietary changes 
and increased rate of infections during the winter months. 
 
The implications of these results need to be analysed further.  In essence, they could 
be used to motivate for the appointment of additional personnel to manage the 
increased patient load experienced during the winter.  They might also be used to 
advise patients at high risk of developing preeclampsia to try and conceive during the 
winter months or that their chance of developing preeclampsia is greatest if they 
conceive in the spring. 
 
Lastly, we feel that this study has shown that further studies on this subject could 
prove invaluable.  A large, multicenter, prospective trial, analysing the degree of 
hypertension and taking an in depth look at the outcomes for both the patients and 
their babies could give valuable information that might change our management of 
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